32 related articles for article (PubMed ID: 18453861)
1. Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes.
Smith MZ; Dale CJ; De Rose R; Stratov I; Fernandez CS; Brooks AG; Weinfurter J; Krebs K; Riek C; Watkins DI; O'connor DH; Kent SJ
J Virol; 2005 Jan; 79(2):684-95. PubMed ID: 15613296
[TBL] [Abstract][Full Text] [Related]
2. Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.
Mwimanzi F; Toyoda M; Mahiti M; Mann JK; Martin JN; Bangsberg D; Brockman MA; Goulder P; Kirchhoff F; Brumme ZL; Ndung'u T; Ueno T
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046444
[TBL] [Abstract][Full Text] [Related]
3. Diversity of MHC class I haplotypes in cynomolgus macaques.
Saito Y; Naruse TK; Akari H; Matano T; Kimura A
Immunogenetics; 2012 Feb; 64(2):131-41. PubMed ID: 21881951
[TBL] [Abstract][Full Text] [Related]
4. Genomic plasticity of the MHC class I A region in rhesus macaques: extensive haplotype diversity at the population level as revealed by microsatellites.
Doxiadis GG; de Groot N; Otting N; Blokhuis JH; Bontrop RE
Immunogenetics; 2011 Feb; 63(2):73-83. PubMed ID: 20949353
[TBL] [Abstract][Full Text] [Related]
5. Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV.
Sugimoto C; Watanabe S; Naruse T; Kajiwara E; Shiino T; Umano N; Ueda K; Sato H; Ohgimoto S; Hirsch V; Villinger F; Ansari AA; Kimura A; Miyazawa M; Suzuki Y; Yamamoto N; Nagai Y; Mori K
PLoS One; 2010 Jul; 5(7):e11678. PubMed ID: 20652030
[TBL] [Abstract][Full Text] [Related]
6. Diversity of MHC class I genes in Burmese-origin rhesus macaques.
Naruse TK; Chen Z; Yanagida R; Yamashita T; Saito Y; Mori K; Akari H; Yasutomi Y; Miyazawa M; Matano T; Kimura A
Immunogenetics; 2010 Sep; 62(9):601-11. PubMed ID: 20640416
[TBL] [Abstract][Full Text] [Related]
7. Impact of cytotoxic-T-lymphocyte memory induction without virus-specific CD4+ T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques.
Tsukamoto T; Takeda A; Yamamoto T; Yamamoto H; Kawada M; Matano T
J Virol; 2009 Sep; 83(18):9339-46. PubMed ID: 19587045
[TBL] [Abstract][Full Text] [Related]
8. Impact of MHC class I diversity on immune control of immunodeficiency virus replication.
Goulder PJ; Watkins DI
Nat Rev Immunol; 2008 Aug; 8(8):619-30. PubMed ID: 18617886
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T-cell epitopes in HIV/SIV infection.
Venet A; Walker BD
AIDS; 1993; 7 Suppl 1():S117-26. PubMed ID: 7689848
[No Abstract] [Full Text] [Related]
10. Houdini's box: towards an understanding of AIDS virus escape from the cytotoxic T-lymphocyte response.
O'Connor DH; Watkins DI
Immunogenetics; 1999 Nov; 50(3-4):237-41. PubMed ID: 10602884
[No Abstract] [Full Text] [Related]
11. Determination of a major histocompatibility complex class I restricting simian immunodeficiency virus Gag241-249 epitope.
Tsukamoto T; Dohki S; Ueno T; Kawada M; Takeda A; Yasunami M; Naruse T; Kimura A; Takiguchi M; Matano T
AIDS; 2008 May; 22(8):993-4. PubMed ID: 18453861
[No Abstract] [Full Text] [Related]
12. Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys.
Yasutomi Y; Palker TJ; Gardner MB; Haynes BF; Letvin NL
J Immunol; 1993 Nov; 151(9):5096-105. PubMed ID: 7691965
[TBL] [Abstract][Full Text] [Related]
13. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.
Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T
J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206
[TBL] [Abstract][Full Text] [Related]
14. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.
Barouch DH; Powers J; Truitt DM; Kishko MG; Arthur JC; Peyerl FW; Kuroda MJ; Gorgone DA; Lifton MA; Lord CI; Hirsch VM; Montefiori DC; Carville A; Mansfield KG; Kunstman KJ; Wolinsky SM; Letvin NL
Nat Immunol; 2005 Mar; 6(3):247-52. PubMed ID: 15685174
[TBL] [Abstract][Full Text] [Related]
15. Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.
Haynes BF; Yasutomi Y; Torres JV; Gardner MB; Langlios AJ; Bolognesi DP; Matthews TJ; Scearce RM; Jones DM; Moody MA
Trans Assoc Am Physicians; 1993; 106():33-41. PubMed ID: 8036743
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
